AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354

Browning, 2004, Molecular mediators of hepatic steatosis and liver injury, J. Clin. Invest., 114, 147, 10.1172/JCI200422422

Cayatte, 2001, S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase, Arterioscler. Thromb. Vasc. Biol., 21, 1577, 10.1161/hq1001.096723

Costet, 2006, Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c, J. Biol. Chem., 281, 6211, 10.1074/jbc.M508582200

Dorn, 2010, Expression of fatty acid synthase in nonalcoholic fatty liver disease, Int. J. Clin. Exp. Pathol., 3, 505

Engelking, 2004, Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis, J. Clin. Invest., 113, 1168, 10.1172/JCI20978

Foretz, 2005, Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver, Diabetes, 54, 1331, 10.2337/diabetes.54.5.1331

Goldstein, 2008, From fatty streak to fatty liver: 33 years of joint publications in the JCI, J. Clin. Invest., 118, 1220, 10.1172/JCI34973

Gwinn, 2008, AMPK phosphorylation of raptor mediates a metabolic checkpoint, Mol. Cell, 30, 214, 10.1016/j.molcel.2008.03.003

Hawley, 2010, Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation, Cell Metab., 11, 554, 10.1016/j.cmet.2010.04.001

Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest., 109, 1125, 10.1172/JCI0215593

Hou, 2008, SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase, J. Biol. Chem., 283, 20015, 10.1074/jbc.M802187200

Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell, 115, 577, 10.1016/S0092-8674(03)00929-2

Kahn, 2005, AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism, Cell Metab., 1, 15, 10.1016/j.cmet.2004.12.003

Laderoute, 2006, 5′-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments, Mol. Cell. Biol., 26, 5336, 10.1128/MCB.00166-06

Li, 2010, Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis, Proc. Natl. Acad. Sci. USA, 107, 3441, 10.1073/pnas.0914798107

Lu, 2006, Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation, Am. J. Physiol. Cell Physiol., 290, C1477, 10.1152/ajpcell.00374.2005

Matsuda, 2001, SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation, Genes Dev., 15, 1206, 10.1101/gad.891301

Raghow, 2008, SREBPs: the crossroads of physiological and pathological lipid homeostasis, Trends Endocrinol. Metab., 19, 65, 10.1016/j.tem.2007.10.009

Schreyer, 2002, LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice, Am. J. Physiol. Endocrinol. Metab., 282, E207, 10.1152/ajpendo.2002.282.1.E207

Semenkovich, 2006, Insulin resistance and atherosclerosis, J. Clin. Invest., 116, 1813, 10.1172/JCI29024

Shimomura, 1997, Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells, J. Clin. Invest., 99, 838, 10.1172/JCI119247

Sundqvist, 2005, Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7, Cell Metab., 1, 379, 10.1016/j.cmet.2005.04.010

Taghibiglou, 2009, Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries, Nat. Med., 15, 1399, 10.1038/nm.2064

Tang, 2011, Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques, Cell Metab., 13, 44, 10.1016/j.cmet.2010.12.004

Um, 2010, AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol, Diabetes, 59, 554, 10.2337/db09-0482

Walker, 2010, Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP, Genes Dev., 24, 1403, 10.1101/gad.1901210

Yahagi, 2002, Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice, J. Biol. Chem., 277, 19353, 10.1074/jbc.M201584200

Yang, 2009, AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells, J. Cell. Biochem., 106, 414, 10.1002/jcb.22024

Ye, 2000, ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs, Mol. Cell, 6, 1355, 10.1016/S1097-2765(00)00133-7

You, 2004, The role of AMP-activated protein kinase in the action of ethanol in the liver, Gastroenterology, 127, 1798, 10.1053/j.gastro.2004.09.049

Young, 2009, A crystallized view of AMPK activation, Cell Metab., 10, 5, 10.1016/j.cmet.2009.06.008

Zang, 2004, AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells, J. Biol. Chem., 279, 47898, 10.1074/jbc.M408149200

Zang, 2006, Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice, Diabetes, 55, 2180, 10.2337/db05-1188

Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action, J. Clin. Invest., 108, 1167, 10.1172/JCI13505

Zuccollo, 2005, The thromboxane A(2) receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus, Circulation, 112, 3001, 10.1161/CIRCULATIONAHA.105.581892